Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation? - Wikidata - wikimedia - TriplyDB

Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?

Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?

http://www.wikidata.org/entity/Q37563875

about

Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen.Outcomes of treatment in men with prostate cancer at the cancer centre Bahamas.

P2860

Q47222084-C53239E9-AD57-4327-AC7C-EB127D525ACD Q50231169-6E520EA4-1DE4-4BE9-9EFC-3F7ADD32782B

P2860

Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?

http://www.wikidata.org/entity/Q37563875

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Classifying high-risk versus v ...... rapy and androgen deprivation?

@en

Classifying high-risk versus v ...... rapy and androgen deprivation?

@nl

type

label

Classifying high-risk versus v ...... rapy and androgen deprivation?

@en

Classifying high-risk versus v ...... rapy and androgen deprivation?

@nl

prefLabel

Classifying high-risk versus v ...... rapy and androgen deprivation?

@en

Classifying high-risk versus v ...... rapy and androgen deprivation?

@nl

P1433

Q37563875-DB50C0BF-65D1-4175-BB36-53103253AABD

P1476

Q37563875-D49CEC5E-ABF8-4B16-A8B3-E559CD951F8B

P2093

Q37563875-1CFAB002-7352-4196-8E3F-5BB248103C3E

Q37563875-356377F1-7D17-425A-B6F0-DA96328433E1

Q37563875-368AB2F2-B854-4E79-8C07-560ECDEB4E3F

Q37563875-4F817AA3-6E52-4B36-A4B8-C734A5377E64

Q37563875-5207ADA8-8405-454D-90A8-2F040B19BA7A

Q37563875-79ED1DFE-C594-43F6-8F58-0033562E59D2

Q37563875-B41BB8F1-546D-4B7A-8E40-8EEC722ED69A

Q37563875-E4C95884-4854-43ED-BA02-464BBCFAED07

Q37563875-F2A9F253-97A1-4661-B36F-5B296F5D79CF

Q37563875-F64266B2-5E83-4801-90AB-8320125A3E0A

P2860

Q37563875-04F5B152-CC02-4242-B77C-B3000CDE5DA3

Q37563875-0612067A-906B-404E-AA3A-DD44CEC500A9

Q37563875-12AEE3DC-23F9-4646-ADEC-A886EA46F232

Q37563875-1F85F6F3-7B5E-4A6A-9053-B3B12BA47D52

Q37563875-3058CADA-1BBC-48E9-8A90-6F6D809536B9

Q37563875-348E1256-08B7-4098-A8E4-C84EBA57AB73

Q37563875-3DE5C7FC-D8FC-418A-8D71-FE5B8987CD4E

Q37563875-43E5F5DB-8101-4AA4-83D7-5F7AF2313947

Q37563875-4FDC53EA-E98A-44C3-9C0E-860D390711BF

Q37563875-54C30718-E17F-4FA1-92B4-B358D3200E87

P2888

Q37563875-32B7CA09-04D6-4B8E-A00C-9DCAAB9A7157

P304

Q37563875-2CED6088-82D3-4BAF-B3D8-0D95B6775AB5

P31

Q37563875-340D0D78-06D7-45B8-9F00-9A486E414B85

P356

Q37563875-5C7F8A22-E2D9-4C21-ADD2-76DFB53B7A15

P433

Q37563875-9059A7F8-AAFA-4654-B962-8CF81E91CF81

P478

Q37563875-ECA6FAA4-A59D-4AB3-A2AC-B13AF22D73F9

P50

Q37563875-16930DF8-BE4A-4CFB-9724-472E6B245235

P577

Q37563875-5A99D100-6455-412B-8D32-3629DDA51CD5

P6179

Q37563875-EE584A74-3614-4B7B-A4AE-7DF7D230561E

P698

Q37563875-04960576-F7B1-4306-9D29-042B1A39683F

P921

Q37563875-570EEABD-A70B-461F-B8EF-DFB0CECAD3C3

P932

Q37563875-24B13B22-352A-4D64-89BE-7BBC95F01FCE

P356

S13014-016-0743-2

P1433

Radiation Oncology

P1476

Classifying high-risk versus v ...... rapy and androgen deprivation?

@en

P2093

Akram Saad

http://www.w3.org/2001/XMLSchema#string

Benjamin Spieler

http://www.w3.org/2001/XMLSchema#string

Damien Urban

http://www.w3.org/2001/XMLSchema#string

Dror Alezra

http://www.w3.org/2001/XMLSchema#string

Ilana Weiss

http://www.w3.org/2001/XMLSchema#string

Jeffrey Goldstein

http://www.w3.org/2001/XMLSchema#string

Lev Tsang

http://www.w3.org/2001/XMLSchema#string

Raanan Berger

http://www.w3.org/2001/XMLSchema#string

Raya Leibowitz-Amit

http://www.w3.org/2001/XMLSchema#string

Tima Davidson

http://www.w3.org/2001/XMLSchema#string

P2860

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial.

Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.

Identification of men with the highest risk of early disease recurrence after radical prostatectomy

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Prognostic Factors for Prostate Cancer Endpoints Following Biochemical Failure: A Review of the Literature.

Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.

Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer.

Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.

P2888

s13014-016-0743-2

P304

5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-016-0743-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Yaacov Richard Lawrence

P577

2017-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039998201

http://www.w3.org/2001/XMLSchema#string

P698

28061904

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5216523

http://www.w3.org/2001/XMLSchema#string